Results 51 to 60 of about 74,040 (257)

Predictors of intracranial hemorrhage in neonatal patients on extracorporeal membrane oxygenation

Scientific Reports, 2023
Extracorporeal membrane oxygenation (ECMO) is a life-supportive treatment in neonatal patients with refractory lung and/or heart failure. Intracranial hemorrhage (ICH) is a severe complication and reliable predictors are warranted. The aims of this study
Sara Wood, Riccardo Iacobelli, Sarah Kopfer, Caroline Lindblad, Eric Peter Thelin, Alexander Fletcher-Sandersjöö, Lars Mikael Broman   +6 more
doaj   +1 more source

Can Cardiopulmonary Rehabilitation Facilitate Weaning of Extracorporeal Membrane Oxygenation (CaRe-ECMO)? Study Protocol for a Prospective Multidisciplinary Randomized Controlled Trial

Frontiers in Cardiovascular Medicine, 2022
Background: Mortality of patients suffering from critical illness has been dramatically improved with advanced technological development of extracorporeal membrane oxygenation (ECMO) therapy.
Yu Zheng, Hao Sun, Yong Mei, Yongxia Gao, Jinru Lv, Dijia Pan, Lu Wang, Xintong Zhang, Deliang Hu, Feng Sun, Wei Li, Gang Zhang, Huazhong Zhang, Ying Chen, Shenrui Wang, Zhongman Zhang, Baoquan Li, Xufeng Chen, Jinsong Zhang, Xiao Lu   +19 more
doaj   +1 more source

Surgical embolectomy for acute massive pulmonary embolism: state of the art [PDF]

, 2018
Massive pulmonary embolism (PE) is a severe condition that can potentially lead to death caused by right ventricular (RV) failure and the consequent cardiogenic shock.
De Bellis, Antonio, D’Abramo, Mizar, Frati, Giacomo, Greco, Ernesto, Iaccarino, Alessandra, Iovine, Elio, Saade, Wael, Schirone, Leonardo, Sciarretta, Sebastiano   +8 more
core   +1 more source

Early Outcomes After Total Arch Replacement With Frozen Elephant Trunk in Elderly Patients With Acute Type A Aortic Dissection

AGING MEDICINE, EarlyView.
Across seven centers (2015–2023), we studied 1634 ATAAD patients undergoing TAR+FET and, after propensity matching (n = 699), compared elderly (≥ 60) versus non‐elderly (< 60) outcomes. Elderly patients had higher 30‐day mortality and complications (log‐rank p = 0.002), supporting individualized hybrid strategies, organ‐protective perioperative care ...
Jiajun Liang, Yuan Xue, Yeting Lou, Hao Han, Xiaohan Zhong, Zhou Liu, Tianxu Han, Meili Wang, Wenjian Jiang, Hongjia Zhang, Haiyang Li, Yuanfei Zhao   +11 more
wiley   +1 more source

ECMO or no ECMO: Do no harm

Anales de Pediatría, 2002
Extracorporeal membrane oxygenation (ECMO) has been used in the management of neonates with life-threatening cardiorespiratory diseases since 19821 . Several studies have demonstrated that ECMO promotes normal survival in neonates with respiratory failure2-4 .
openaire   +2 more sources

“Intrapericardial Approach” for Venous Outflow Reconstruction in Living‐Donor Liver Transplantation for Budd‐Chiari Syndrome: Surgical Techniques and LongTerm Outcomes

Annals of Gastroenterological Surgery, EarlyView.
Unlike deceased‐donor liver transplantation, living‐donor liver transplantation (LDLT) for Budd‐Chiari Syndrome (BCS) presents distinctive challenges in hepatic venous (HV)‐outflow reconstruction because diseased HV–inferior vena cava (IVC) cannot be entirely replaced with healthy donor vessels.
Koichiro Hata, Tetsuya Tajima, Satoshi Ogiso, Shinji Uemoto, Etsuro Hatano   +4 more
wiley   +1 more source

Incidence and predictors of brain infarction in neonatal patients on extracorporeal membrane oxygenation: an observational cohort study

Scientific Reports, 2022
To determine the incidence and identify predictors of brain infarctions (BI) in neonatal patients treated with extracorporeal membrane oxygenation (ECMO). We performed a retrospective cohort study at ECMO Centre Karolinska, Stockholm, Sweden.
Sarah Kopfer, Riccardo Iacobelli, Sara Wood, Caroline Lindblad, Eric Peter Thelin, Alexander Fletcher-Sandersjöö, Lars Mikael Broman   +6 more
doaj   +1 more source

Conversion from Venovenous to Venoarterial Extracorporeal Membrane Oxygenation in Adults

Membranes, 2021
No major study has been performed on the conversion from venovenous (VV) to venoarterial (VA) extracorporeal membrane oxygenation (ECMO) in adults. This single-center retrospective cohort study aimed to investigate the incidence, indication, and outcome ...
Lars Falk, Alexander Fletcher-Sandersjöö, Jan Hultman, Lars Mikael Broman   +3 more
doaj   +1 more source

Intravenous lanadelumab for the treatment of moderately ill COVID‐19 patients

British Journal of Clinical Pharmacology, EarlyView.
Aims Kallikrein‐kinin system (KKS) dysregulation is hypothesized to play a pathogenetic role in COVID‐19‐associated pulmonary oedema. To investigate the efficacy and safety of intravenous lanadelumab, a monoclonal antibody that inhibits plasma kallikrein, in COVID‐19, we conducted a phase 2, open‐label, randomized‐controlled, proof‐of‐concept ...
Job J. Engel, Christine van Linge, W. Joost Wiersinga, Ilse J. E. Kouijzer, Quirijn de Mast, Robert‐Jan Hassing, Danique J. H. Huijbens, Helen L. Leavis, Roger Schutgens, Coen Maas, Kit C. B. Roes, Frank L. van de Veerdonk, Roger Brüggemann   +12 more
wiley   +1 more source

Canulación yugulo-subclavia de ECMO-VA en shock cardiogénico por tromboembolia pulmonar y síndrome de hipercoagulabilidad

Revista Colombiana de Cardiología
El uso de soporte vital extracorpóreo es una opción en pacientes con shock cardiogénico secundario a insuficiencia ventricular derecha y tromboembolia pulmonar.
Leonardo A. Salazar-Rojas, Juan Porras, Claudia C. Colmenares-Mejía, Valentina Pinzón   +3 more
doaj   +1 more source